ProShare Advisors’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-59,354
| Closed | -$52.6K | – | 1942 |
|
|
2022
Q4 | $52.6K | Buy |
59,354
+17,443
| +42% | +$15.5K | ﹤0.01% | 1734 |
|
|
2022
Q3 | $66K | Sell |
41,911
-801
| -2% | -$1.26K | ﹤0.01% | 1627 |
|
|
2022
Q2 | $86K | Sell |
42,712
-13,302
| -24% | -$26.8K | ﹤0.01% | 1633 |
|
|
2022
Q1 | $131K | Sell |
56,014
-9,251
| -14% | -$21.6K | ﹤0.01% | 1983 |
|
|
2021
Q4 | $303K | Buy |
65,265
+29,662
| +83% | +$138K | ﹤0.01% | 1782 |
|
|
2021
Q3 | $272K | Sell |
35,603
-35,127
| -50% | -$268K | ﹤0.01% | 1616 |
|
|
2021
Q2 | $685K | Buy |
70,730
+3,844
| +6% | +$37.2K | ﹤0.01% | 1289 |
|
|
2021
Q1 | $553K | Buy |
66,886
+11,437
| +21% | +$94.6K | ﹤0.01% | 1372 |
|
|
2020
Q4 | $378K | Buy |
55,449
+28,313
| +104% | +$193K | ﹤0.01% | 1447 |
|
|
2020
Q3 | $303K | Buy |
27,136
+3,303
| +14% | +$36.9K | ﹤0.01% | 1168 |
|
|
2020
Q2 | $150K | Buy |
+23,833
| New | +$150K | ﹤0.01% | 1520 |
|
|
2020
Q1 | – | Sell |
-16,961
| Closed | -$57K | – | 1678 |
|
|
2019
Q4 | $57K | Buy |
16,961
+2,709
| +19% | +$9.1K | ﹤0.01% | 1741 |
|
|
2019
Q3 | $30K | Buy |
14,252
+2,118
| +17% | +$4.46K | ﹤0.01% | 1633 |
|
|
2019
Q2 | $32K | Sell |
12,134
-318
| -3% | -$839 | ﹤0.01% | 1595 |
|
|
2019
Q1 | $59K | Buy |
12,452
+934
| +8% | +$4.43K | ﹤0.01% | 1606 |
|
|
2018
Q4 | $28K | Sell |
11,518
-1,857
| -14% | -$4.51K | ﹤0.01% | 1544 |
|
|
2018
Q3 | $59K | Buy |
13,375
+1,924
| +17% | +$8.49K | ﹤0.01% | 1713 |
|
|
2018
Q2 | $82K | Buy |
+11,451
| New | +$82K | ﹤0.01% | 1729 |
|